These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 18443899
1. Proton MR spectroscopy of the breast. Tozaki M. Breast Cancer; 2008; 15(3):218-23. PubMed ID: 18443899 [Abstract] [Full Text] [Related]
2. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. Hsieh TJ, Li CW, Chuang HY, Liu GC, Wang CK. J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465 [Abstract] [Full Text] [Related]
6. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Jagannathan NR, Kumar M, Seenu V, Coshic O, Dwivedi SN, Julka PK, Srivastava A, Rath GK. Br J Cancer; 2001 Apr 20; 84(8):1016-22. PubMed ID: 11308247 [Abstract] [Full Text] [Related]
7. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Bartella L, Morris EA, Dershaw DD, Liberman L, Thakur SB, Moskowitz C, Guido J, Huang W. Radiology; 2006 Jun 20; 239(3):686-92. PubMed ID: 16603660 [Abstract] [Full Text] [Related]
8. Human breast lesions: characterization with proton MR spectroscopy. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Radiology; 1998 Oct 20; 209(1):269-75. PubMed ID: 9769842 [Abstract] [Full Text] [Related]
10. Proton magnetic resonance spectroscopy of tubercular breast abscess: report of a case. Das CJ, Medhi K. J Comput Assist Tomogr; 2008 Oct 20; 32(4):599-601. PubMed ID: 18664848 [Abstract] [Full Text] [Related]
11. In vivo proton MR spectroscopy of the breast. Stanwell P, Mountford C. Radiographics; 2007 Oct 20; 27 Suppl 1():S253-66. PubMed ID: 18180231 [Abstract] [Full Text] [Related]
14. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions. Dorrius MD, Pijnappel RM, Jansen-van der Weide MC, Jansen L, Kappert P, Oudkerk M, Sijens PE. Radiology; 2011 Jun 20; 259(3):695-703. PubMed ID: 21460033 [Abstract] [Full Text] [Related]
15. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Bartella L, Thakur SB, Morris EA, Dershaw DD, Huang W, Chough E, Cruz MC, Liberman L. Radiology; 2007 Oct 20; 245(1):80-7. PubMed ID: 17885182 [Abstract] [Full Text] [Related]
16. Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant? Baltzer PA, Gussew A, Dietzel M, Rzanny R, Gajda M, Camara O, Reichenbach JR, Kaiser WA. NMR Biomed; 2012 Jan 20; 25(1):67-74. PubMed ID: 21557368 [Abstract] [Full Text] [Related]
17. Quantitative multivoxel proton chemical shift imaging of the breast. Sijens PE, Dorrius MD, Kappert P, Baron P, Pijnappel RM, Oudkerk M. Magn Reson Imaging; 2010 Apr 20; 28(3):314-9. PubMed ID: 20071119 [Abstract] [Full Text] [Related]